GlassScriptPhysician profile
David A Vittetoe
NPI 1790749174
$2,704.82
in general payments reported to CMS, 2019-2025
11 companies · $664 in 2025
The $664 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $354 · 2020: $280 · 2021: $1,130 · 2022: $42.31 · 2023: $211 · 2024: $25.09 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $899.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,087.88 | 2019-2025 | Comprehensive Shoulder System, Osseotite, Rosa |
| Depuy Synthes Sales INC. | $142.97 | 2019-2025 | Monovisc, Orthovisc |
| Smith+Nephew, INC. | $87.90 | 2025 | Real Intelligence |
| Bone Support INC. | $74.91 | 2020 | |
| Heron Therapeutics, INC. | $69.59 | 2021-2023 | Zynrelef |
| Pacira Pharmaceuticals Incorporated | $62.75 | 2023-2024 | Zilretta, Iovera, Exparel |
| Pacira Therapeutics, INC. | $58.11 | 2019-2020 | |
| Stryker Corporation | $34.75 | 2025 | Pangea |
| Moximed, INC | $30.32 | 2025 | Misha Knee System, Small, Left |
| Fidia Pharma USA INC. | $28.04 | 2025 | Hymhyn |
| Heraeus Medical, LLC. | $27.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Vittetoe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.